Open access peer-reviewed Edited Volume

Flow Cytometry

Bhawana Singh

Banaras Hindu University

An aspiring scientist working on the development of host-directed immunotherapy, holder of an International Young Scientist Award, and a member of the International Society of Infectious Diseases. Dr. Singh has worked with scientists from Cambridge University, Karolinska Institute, Queensland Institute of Medical Research and has obtained her postdoctoral experience at Wexner Medical Center, The Ohio State University, Columbus, USA.


Multiparametric Flow Cytometry Mutations Protein Analysis Immune Competence Disease Relapse Imaging Flow Cytometry Flow-FISH Polychromatic Flow Cytometry Mass Cytometry Immune Reconstitution DNA Analysis Fingerprinting

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

Immune dysregulation remains is the major cause for the development of different kinds of diseases. In recent decades, flow cytometry has emerged as an essential tool for real-time analysis of the cellular components and understanding the intricacies of immunological pathways. Flow cytometry-based immunophenotyping has greatly facilitated the descriptive understanding of the immune cells as well as their subsets for a better understanding of the disease pathophysiology, development of biomarkers for diagnosis, and identification of potential therapeutic targets. In the field of cancer biology, flow cytometric application has opened the doors for the study of different stages of cancer and helped in tailoring the drug dosage for therapeutic benefits. Furthermore, different cutting-edge innovations in the field of flow cytometry have led to the identification of the immune cell signatures associated with diseases therefore, it has served as a robust, sensitive, and all-inclusive platform for understanding diseases and their management. The clinical application of flow cytometric-based assays covers a diverse range of diseases including infectious diseases, minimal residual disease, organ transplantation, immunodeficiency diseases, post-operative monitoring, hemorrhage, blood transfusion, T-cell cross-matching, and platelet analysis are to name a few.

This book aims to provide an insight into the flow cytometric modality for explaining the disease etiology. It will broadly cover the flow cytometric-based molecular applications, innovations, and recent biomedical advances in unveiling disease prognostics, diagnostics, immunopathology, and therapeutics.

Publishing process

Book initiated and editor appointed

Date completed: September 28th 2021

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline for chapter proposals: October 26th 2021

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Register for the book

Approved chapters written in full and submitted

Deadline for full chapters: December 25th 2021

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: March 15th 2022

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: May 14th 2022

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Bhawana Singh

Banaras Hindu University

Dr. Bhawana Singh is currently working as a scientist in the Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, India, where she also obtained her Ph.D. working on immuno-genetic aspects of visceral leishmaniasis. She has a broad background in cellular and molecular immunology in parasitic disease with significant epidemiological and field experience working with human subjects. During her Ph.D., Dr. Singh received training at QIMR Berghofer Medical Research Institute, Brisbane, Australia, and presented her work on several international platforms. Her research has been published in peer-reviewed international journals of repute. She obtained post-doctoral experience at Wexner Medical Center, The Ohio State University, Columbus, USA. There, she worked on host-directed immunotherapy for relieving immunosuppression in chronic diseases using immunomodulators.

View profile

Book chapters authored 1

Books edited 1

Introducing your Author Service Manager

Ms. Zrinka Tomicic

Ask a question

Book will be abstracted and indexed in